Application of Left Axillary Incision in Patent Ductus Arteriosus Ligation

Background: Left posterolateral incision has been a conventional incision for patent ductus arteriosus ligation. This study aimed to evaluate the efficacy and safety of left axillary thoracotomy for patent ductus arteriosus ligation. Methods: Between January 2013 and December 2019, the clinical data of 76 patients who underwent left axillary thoracotomy for patent ductus arteriosus ligation were compared with the data of a paired group of 101 patients who underwent left posterolateral thoracotomy. Results: Compared with the left posterolateral group, the left axillary group showed less drainage (P < 0.05). Operation time, postoperative mechanical ventilation time, and postoperative hospitalization duration were similar between the groups. Complications were rare in both groups with no mortality during follow up. In total, 72 patient families (95%) in the left axillary group and 81 patient families (80%) in the left posterolateral group were satisfied with their cosmetic results (P < 0.01). Conclusions: A left axillary thoracotomy is as safe and effective as a left posterolateral thoracotomy for patent ductus arteriosus ligation. With lower trauma and better cosmetic results, this procedure provides a good alternative to the standard left posterolateral thoracotomy.

Download Full-text

Scoliosis in Patients with Aortic Coarctation and Patent Ductus Arteriosus: Does Standard Posterolateral Thoracotomy Play a Role in the Development of the Lateral Curve of the Spine?

Pediatric Cardiology ◽

10.1007/s00246-009-9469-3 ◽

2009 ◽

Vol 30 (7) ◽

pp. 941-945 ◽

Cited By ~ 28

Author(s):

Marek Roclawski ◽

Robert Sabiniewicz ◽

Piotr Potaz ◽

Andrzej Smoczynski ◽

Rafal Pankowski ◽

...

Keyword(s):

Patent Ductus Arteriosus ◽

Aortic Coarctation ◽

Ductus Arteriosus ◽

Posterolateral Thoracotomy ◽

Patent Ductus

Download Full-text

Comparison of Posterolateral Thoracotomy and Video-Assisted Thoracoscopic Clipping for the Treatment of Patent Ductus Arteriosus in Neonates and Infants

Pediatric Cardiology ◽

10.1007/s00246-010-9863-x ◽

2010 ◽

Vol 32 (4) ◽

pp. 386-390 ◽

Cited By ~ 18

Author(s):

Haiyu Chen ◽

Guoxing Weng ◽

Zhiqun Chen ◽

Huan Wang ◽

Qi Xie ◽

...

Keyword(s):

Patent Ductus Arteriosus ◽

Ductus Arteriosus ◽

Posterolateral Thoracotomy ◽

Video Assisted ◽

Neonates And Infants ◽

Patent Ductus

Download Full-text

Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder

Cardiology in the Young ◽

10.1017/s1047951114000183 ◽

2014 ◽

Vol 25 (3) ◽

pp. 491-495 ◽

Cited By ~ 7

Author(s):

José A. García-Montes ◽

Anahí Camacho-Castro ◽

Juan P. Sandoval-Jones ◽

Alfonso Buendía-Hernández ◽

Juan Calderón-Colmenero ◽

...

Keyword(s):

Patent Ductus Arteriosus ◽

Septal Defect ◽

Ductus Arteriosus ◽

Systolic Pressure ◽

Good Alternative ◽

Pulmonary Artery Systolic Pressure ◽

Amplatzer Septal Occluder ◽

Residual Shunt ◽

Patent Ductus

AbstractBackground: Percutaneous closure of patent ductus arteriosus has become the treatment of choice in many centres. In patients with large ducts and pulmonary hypertension, transcatheter closure has been achieved with success using the Amplatzer Duct Occluder or even the Amplatzer Muscular Ventricular Septal Defect Occluder. Materials and methods: We present a series of 17 patients with large and hypertensive ductus arteriosus who were treated with an Amplatzer Septal Occluder. The group had 11 female patients (64.7%) and a mean age of 18.6±12.1 years. Results: The haemodynamic and anatomical data are as follows: pulmonary artery systolic pressure 71.3±31.8 mmHg, pulmonary to systemic flow ratio 3.14±1.36, ductal diameter at the pulmonary end 12.5±3.8 mm, and at the aortic end 20.2±7.7 mm; 14 cases (82.3%) had type A ducts. In 11 patients, we began the procedure using a different device – six with duct occluder and five with ventricular septal occluder – and it was changed because of device embolisation in six (35.3%). All septal occluders were delivered successfully. Residual shunt was moderate in six patients (35.3%), mild in eight (47%), trivial in two (11.8%), and no shunt in one (5.9%). Pulmonary systolic pressure decreased to 48.9±10.8 mmHg after occlusion (p=0.0015). Follow-up in 15 patients (88.2%) for 28.4±14.4 months showed complete closure in all cases but one, and continuous decrease of the pulmonary systolic pressure to 31.4±10.5 mmHg. No complications at follow-up have been reported. Conclusions: The Amplatzer Septal Occluder is a good alternative to percutaneously treat large and hypertensive ductus arteriosus.

Download Full-text